Organogenesis Holdings Inc reports results for the quarter ended in March - Earnings Summary

Organogenesis Holdings

10/05/2021 23:39

* Organogenesis Holdings Inc  ORGO.OQ  reported quarterly
adjusted earnings of 7 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 2 cents per share.
* Revenue rose 66.1% to $102.55 million from a year ago​; 
analysts expected $87.57 million.
* Organogenesis Holdings Inc's reported EPS for the quarter was
7 cents​.
* The mean earnings estimate of analysts had risen by about 65%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Organogenesis Holdings Inc shares had risen by 16.1% this
quarter and gained 180.9% so far this year.
* The company reported quarterly net income of $9.94 million.
* Wall Street's median 12-month price target for Organogenesis
Holdings Inc is $24.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 10 at 10:39 p.m. GMT.
​All figures in $